Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate versus acetazolamide in infants with external hydrocephalus
IRCT20201105049278N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of topiramate and acetazolamide in hydrocephalus (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Head circumference, Motor developmental status and 3 more. Started Sep 2020; status: completed.
02
Drugs
topiramateacetazolamide
03
Conditions
hydrocephalus
Beyond the preview
Go deeper on IRCT20201105049278N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201105049278N1.